1. Clinical Overview
Diatrizoic Acid (65%) is a high-osmolality, ionic, iodinated contrast medium used for radiographic imaging. It is a tri-iodinated benzoic acid derivative (sodium and meglumine salts) that provides radiopacity by attenuating X-rays. It is primarily used for intravascular, intra-arterial, and body cavity administration to visualize vascular structures and hollow organs. Its high osmolality (approximately 1500 mOsm/kg) is a key differentiating factor from newer low-osmolality agents.
| Onset | Duration | Bioavailability |
|---|---|---|
| Immediate upon intravascular injection; peak opacification occurs within seconds. | Contrast effect lasts for the duration of the imaging procedure, typically 5-30 minutes, depending on vascular flow and organ function. | 100% upon intravascular administration. Not applicable for oral absorption as it is not intended for systemic effect via the GI tract. |
2. Mechanism of Action
Diatrizoic Acid provides radiographic contrast by virtue of its high iodine content (approximately 65% by weight). Iodine atoms have a high atomic number (53), which results in significant attenuation (absorption) of X-ray photons. When injected into blood vessels or body cavities, it creates a density difference between the fluid-filled space and surrounding tissues, making lumens and vascular structures visible on X-ray or fluoroscopy.
3. Indications & Uses
- Intravenous Urography (IVU) / Excretory Urography
- Peripheral Arteriography and Venography
- Cardiac Angiography (with caution)
- Aortography
- Digital Subtraction Angiography (DSA)
4. Dosage & Administration
Adult Dosage: Dose is volume and concentration dependent on the procedure and patient size. Typical ranges: IV Urography: 25-50 mL (65%); Angiography: Varies by vessel, e.g., 10-40 mL per injection for aortic studies. Maximum single dose should not exceed 200 mL of the 65% solution.
Administration: For intravascular use: Administer by slow IV injection or controlled IV infusion/injection using an angiographic catheter. Warm solution to body temperature to reduce viscosity. Use strict aseptic technique. Observe patient closely during and for at least 30 minutes after injection. Pre-procedure hydration with 0.9% NaCl is recommended. Test injection is NOT a reliable predictor of severe reactions.
5. Side Effects
Common side effects may include:
- Sensation of warmth/flushing (70-80%)
- Metallic taste
- Nausea
- Vomiting
- Pain at injection site
- Mild urticaria (hives)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Metformin | Increased risk of lactic acidosis if contrast-induced nephropathy occurs. Must withhold metformin before and after procedure. | Major |
| Interleukin-2 | Increased risk of delayed adverse reactions to contrast media. | Moderate |
| Beta-blockers (e.g., Propranolol) | May impair response to treatment of anaphylactoid reactions (refractory bradycardia, bronchospasm). | Moderate |
| Nephrotoxic drugs (Aminoglycosides, NSAIDs, Amphotericin B) | Additive risk of acute kidney injury. | Major |
| Diuretics (especially Loop Diuretics) | May exacerbate dehydration and increase risk of nephrotoxicity. | Moderate |
7. Patient Counselling
- DO inform your doctor about all allergies, especially to iodine, shellfish, or previous contrast reactions.
- DO inform your doctor about all medications, including over-the-counter drugs and herbal supplements.
- DO inform about any history of kidney disease, diabetes, asthma, thyroid problems, or heart disease.
- DO follow pre-procedure instructions regarding fasting and hydration.
- DO report any unusual sensations (itching, shortness of breath, chest pain) immediately during the procedure.
- DONT drive yourself home after the procedure if you feel unwell.
- DONT schedule the procedure if you suspect you might be pregnant.
8. Toxicology & Storage
Overdose: Symptoms are extensions of its adverse effects: Severe cardiovascular disturbances (pulmonary edema, heart failure, arrhythmias, shock), severe renal failure, seizures, severe electrolyte imbalance (hyperosmolality), and death.
Storage: Store at a temperature not exceeding 30°C. Protect from light and freezing. Keep the vial in the outer carton. Do not use if the solution is discolored or contains particulate matter. The solution should be clear and colorless to pale yellow. Once the vial is punctured, use immediately. Discard any unused portion.